Manhattan Scientifics, Inc.
MHTX
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 58.64% | -50.39% | 3.05% | -14.41% | 45.48% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.05% | 84.47% | 25.61% | 90.70% | -81.62% |
| Change in Net Operating Assets | -4.67% | 9.49% | -4.20% | 18.18% | 9.01% |
| Cash from Operations | 59.52% | -200.00% | 62.16% | 42.19% | 14.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -84.62% | 425.00% | -109.52% | 223.08% | -- |
| Cash from Investing | -84.62% | 425.00% | -109.52% | 223.08% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 100.00% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.75% | 27.27% | -159.46% | 197.37% | 55.29% |
